000			02158 a2200613 4500
005			20250516114448.0
264		0	_c20130627
008			201306s 0 0 eng d
022			_a1557-8534
024	7		_a10.1089/scd.2012.0267 _2doi
040			_aNLM _beng _cNLM
100	1		_aMoschidou, Dafni
245	0	0	_aHuman mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics. _h[electronic resource]
260			_bStem cells and development _cFeb 2013
300			_a444-58 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAmniotic Fluid _xcytology
650	0	4	_aAnimals
650	0	4	_aAntigens, Differentiation _xgenetics
650	0	4	_aCell Proliferation
650	0	4	_aCell Shape
650	0	4	_aCells, Cultured
650	0	4	_aCulture Media
650	0	4	_aEmbryonic Stem Cells _xmetabolism
650	0	4	_aFemale
650	0	4	_aGene Expression
650	0	4	_aHistone Deacetylase Inhibitors _xpharmacology
650	0	4	_aHumans
650	0	4	_aKruppel-Like Factor 4
650	0	4	_aKruppel-Like Transcription Factors _xgenetics
650	0	4	_aMesenchymal Stem Cells _xmetabolism
650	0	4	_aMice
650	0	4	_aNeoplasms, Experimental _xpathology
650	0	4	_aOctamer Transcription Factor-3 _xgenetics
650	0	4	_aPluripotent Stem Cells _xdrug effects
650	0	4	_aPregnancy
650	0	4	_aPregnancy Trimester, Second
650	0	4	_aProto-Oncogene Proteins c-myc _xgenetics
650	0	4	_aSOXB1 Transcription Factors _xgenetics
650	0	4	_aTelomere _xmetabolism
650	0	4	_aTeratoma _xpathology
650	0	4	_aUp-Regulation _xdrug effects
650	0	4	_aValproic Acid _xpharmacology
700	1		_aMukherjee, Sayandip
700	1		_aBlundell, Michael P
700	1		_aJones, Gemma N
700	1		_aAtala, Anthony J
700	1		_aThrasher, Adrian J
700	1		_aFisk, Nicholas M
700	1		_aDe Coppi, Paolo
700	1		_aGuillot, Pascale V
773	0		_tStem cells and development _gvol. 22 _gno. 3 _gp. 444-58
856	4	0	_uhttps://doi.org/10.1089/scd.2012.0267 _zAvailable from publisher's website
999			_c22170998 _d22170998